The Lancet Respiratory Medicine in conversation with
En podcast av The Lancet Group
156 Avsnitt
-
Tuberculosis and the microbiome
Publicerades: 2019-09-03 -
Antibiotics and non-severe exacerbations of bronchiectasis in children
Publicerades: 2019-08-16 -
Use of extended-criteria donors for lung transplantation
Publicerades: 2019-08-06 -
α1-antitrypsin deficiency testing
Publicerades: 2019-07-30 -
Live-attenuated influenza vaccines in children
Publicerades: 2019-06-24 -
Clearing the air on ambient air pollution
Publicerades: 2019-06-19 -
A second look at FEAST
Publicerades: 2019-06-12 -
Intensive care units and the USA
Publicerades: 2019-05-21 -
A respiratory family affair
Publicerades: 2019-04-17 -
A global approach to children's asthma
Publicerades: 2019-02-22 -
The effectiveness of pleural manometry
Publicerades: 2019-02-14 -
Lung volume reduction and emphysema
Publicerades: 2019-02-08 -
Glimmers of hope for MDR-Tuberculosis treatment
Publicerades: 2019-01-08 -
Effectiveness of flu vaccine over time
Publicerades: 2018-11-16 -
Towards an International Pneumonia Network
Publicerades: 2018-11-12 -
Laparoscopic anti-reflux surgery and IPF
Publicerades: 2018-11-02 -
Improving the lives of patients with bronchiectasis
Publicerades: 2018-09-20 -
Deep learning and fibrotic lung disease
Publicerades: 2018-09-17 -
Critical care and infant nutrition
Publicerades: 2018-09-15 -
Precision medicine in ARDS
Publicerades: 2018-08-03
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
